Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitelaw, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Whitelaw, W.

Chest, Vol 99, 1507-1510, Copyright © 1991 by American College of Chest Physicians

ARTICLES

Asthma deaths

WA Whitelaw
Division of Respiratory Medicine and Critical Care, Faculty of Medicine, University of Calgary, Alberta, Canada.

Deaths from asthma seem to be increasing in spite of considerable improvements in drug treatment and management plans. There are many hypotheses to explain this, but little emphasis has been placed on the possibility that confidence in better drug treatments may modify patients' behavior so as to place them at greater risk of illness. It is well recognized that excessive confidence in bronchodilator inhalers and nebulizers can make patients stay away from hospitals too long during acute attacks. It is also very possible that prevention of symptoms by use of antiasthma drugs could allow patients to spend more time in environments containing antigens or other agents that provoke asthma, resulting in more serious and long-lasting bronchial inflammation and reactivity.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American College of Chest Physicians.